The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Tryptophan metabolism: entering the field of aging and age-related pathologies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Influence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033
Research works printed but not linked: 75
- Scully, 2012, Demography: To the limit, Nature, 492, S2, 10.1038/492S2a · DOI
- Mair, 2008, Aging and survival: the genetics of life span extension by dietary restriction, Annu. Rev. Biochem., 77, 727, 10.1146/annurev.biochem.77.061206.171059 · DOI · Paper page
- Greer, 2009, Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans, Aging Cell, 8, 113, 10.1111/j.1474-9726.2009.00459.x · DOI · Paper page
- Kenyon, 2010, The genetics of ageing, Nature, 464, 504, 10.1038/nature08980 · DOI · Paper page
- Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
- Bjedov, 2010, Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster, Cell Metab., 11, 35, 10.1016/j.cmet.2009.11.010 · DOI · Paper page
- Wu, 2002, Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis, Cancer Res., 62, 1030
- Morley, 2002, The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans, Proc. Natl. Acad. Sci. U.S.A., 99, 10417, 10.1073/pnas.152161099 · DOI · Paper page
- Cohen, 2006, Opposing activities protect against age-onset proteotoxicity, Science, 313, 1604, 10.1126/science.1124646 · DOI · Paper page
- Killick, 2009, Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice, Biochem. Biophys. Res. Commun., 386, 257, 10.1016/j.bbrc.2009.06.032 · DOI
- Cohen, 2009, Reduced IGF-1 signaling delays age-associated proteotoxicity in mice, Cell, 139, 1157, 10.1016/j.cell.2009.11.014 · DOI · Paper page
- Anisimov, 2010, Rapamycin extends maximal lifespan in cancer-prone mice, Am. J. Pathol., 176, 2092, 10.2353/ajpath.2010.091050 · DOI · Paper page
- Bove, 2011, Fighting neurodegeneration with rapamycin: mechanistic insights, Nat. Rev. Neurosci., 12, 437, 10.1038/nrn3068 · DOI · Paper page
- Stone, 2002, Endogenous kynurenines as targets for drug discovery and development, Nat. Rev. Drug Discov., 1, 609, 10.1038/nrd870 · DOI · Paper page
- van der Goot, 2012, Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation, Proc. Natl. Acad. Sci. U.S.A., 109, 14912, 10.1073/pnas.1203083109 · DOI · Paper page
- Oxenkrug, 2010, The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine, J. Neural Transm., 117, 23, 10.1007/s00702-009-0341-7 · DOI
- Schroecksnadel, 2011, Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells, Transpl. Immunol., 25, 119, 10.1016/j.trim.2011.06.005 · DOI
- Kanai, 2009, Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice, Mol. Brain, 2, 8, 10.1186/1756-6606-2-8 · DOI · Paper page
- Mellor, 2003, Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion, J. Immunol., 171, 1652, 10.4049/jimmunol.171.4.1652 · DOI · Paper page
- Frick, 2004, Increasing production of homocysteine and neopterin and degradation of tryptophan with older age, Clin. Biochem., 37, 684, 10.1016/j.clinbiochem.2004.02.007 · DOI · Paper page
- Pertovaara, 2006, Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality, Mech. Ageing Dev., 127, 497, 10.1016/j.mad.2006.01.020 · DOI
- Friberg, 2002, Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection, Int. J. Cancer, 101, 151, 10.1002/ijc.10645 · DOI · Paper page
- Pilotte, 2012, Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase, Proc. Natl. Acad. Sci. U.S.A., 109, 2497, 10.1073/pnas.1113873109 · DOI · Paper page
- Giorgini, 2005, A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease, Nat. Genet., 37, 526, 10.1038/ng1542 · DOI · Paper page
- Campesan, 2011, The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease, Curr. Biol., 21, 961, 10.1016/j.cub.2011.04.028 · DOI · Paper page
- Zwilling, 2011, Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration, Cell, 145, 864, 10.1016/j.cell.2011.05.020 · DOI · Paper page
- Le Floc’h, 2011, Tryptophan metabolism, from nutrition to potential therapeutic applications, Amino Acids, 41, 1195, 10.1007/s00726-010-0752-7 · DOI · Paper page
- Yoshida, 1981, Induction of pulmonary indoleamine 2,3-dioxygenase by interferon, Proc. Natl. Acad. Sci. U.S.A., 78, 129, 10.1073/pnas.78.1.129 · DOI · Paper page
- Hayaishi, 1978, Specific induction of pulmonary indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide, Ciba Found. Symp., 65, 199
- Guillemin, 2001, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection, J. Neurochem., 78, 842, 10.1046/j.1471-4159.2001.00498.x · DOI · Paper page
- Fukui, 1991, Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism, J. Neurochem., 56, 2007, 10.1111/j.1471-4159.1991.tb03460.x · DOI · Paper page
- Pfefferkorn, 1984, Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. U.S.A., 81, 908, 10.1073/pnas.81.3.908 · DOI · Paper page
- Gupta, 1994, Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts, Infect. Immun., 62, 2277, 10.1128/IAI.62.6.2277-2284.1994 · DOI
- MacKenzie, 1999, Growth inhibition of multiresistant enterococci by interferon-γ-activated human uro-epithelial cells, J. Med. Microbiol., 48, 935, 10.1099/00222615-48-10-935 · doi:10.1099/00222615-48-10-935
- Munn, 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281, 1191, 10.1126/science.281.5380.1191 · DOI · Paper page
- Mellor, 2001, Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy, Nat. Immunol., 2, 64, 10.1038/83183 · DOI · Paper page
- Munn, 2007, Indoleamine 2,3-dioxygenase and tumor-induced tolerance, J. Clin. Invest., 117, 1147, 10.1172/JCI31178 · DOI · Paper page
- Munn, 1999, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J. Exp. Med., 189, 1363, 10.1084/jem.189.9.1363 · DOI · Paper page
- Lee, 2002, Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division, Immunology, 107, 452, 10.1046/j.1365-2567.2002.01526.x · DOI · Paper page
- Rohde, 2001, The TOR kinases link nutrient sensing to cell growth, J. Biol. Chem., 276, 9583, 10.1074/jbc.R000034200 · DOI · Paper page
- Gao, 2002, Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling, Nat. Cell Biol., 4, 699, 10.1038/ncb847 · DOI · Paper page
- Zhang, 2002, The GCN2 eIF2α kinase is required for adaptation to amino acid deprivation in mice, Mol. Cell. Biol., 22, 6681, 10.1128/MCB.22.19.6681-6688.2002 · DOI · Paper page
- Harding, 2000, Regulated translation initiation controls stress-induced gene expression in mammalian cells, Mol. Cell, 6, 1099, 10.1016/S1097-2765(00)00108-8 · DOI · Paper page
- Munn, 2005, GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase, Immunity, 22, 633, 10.1016/j.immuni.2005.03.013 · DOI · Paper page
- Fallarino, 2006, The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells, J. Immunol., 176, 6752, 10.4049/jimmunol.176.11.6752 · DOI · Paper page
- Fallarino, 2002, T cell apoptosis by tryptophan catabolism, Cell Death Differ., 9, 1069, 10.1038/sj.cdd.4401073 · DOI · Paper page
- Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase, J. Exp. Med., 196, 459, 10.1084/jem.20020121 · DOI · Paper page
- Terness, 2002, Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites, J. Exp. Med., 196, 447, 10.1084/jem.20020052 · DOI · Paper page
- Wirleitner, 2003, Immune activation and degradation of tryptophan in coronary heart disease, Eur. J. Clin. Invest., 33, 550, 10.1046/j.1365-2362.2003.01186.x · DOI · Paper page
- Niinisalo, 2008, Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study, Scand. J. Clin. Lab. Invest., 68, 767, 10.1080/00365510802245685 · DOI
- Pedersen, 2011, Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease, Arterioscler. Thromb. Vasc. Biol., 31, 698, 10.1161/ATVBAHA.110.219329 · DOI
- Lob, 2009, Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?, Nat. Rev. Cancer, 9, 445, 10.1038/nrc2639 · DOI · Paper page
- Platten, 2012, Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion, Cancer Res., 72, 5435, 10.1158/0008-5472.CAN-12-0569 · DOI · Paper page
- Stone, 2013, An expanding range of targets for kynurenine metabolites of tryptophan, Trends Pharmacol. Sci., 34, 136, 10.1016/j.tips.2012.09.006 · DOI · Paper page
- Savvateeva, 2000, Age-dependent memory loss, synaptic pathology and altered brain plasticity in the Drosophila mutant cardinal accumulating 3-hydroxykynurenine, J. Neural Transm., 107, 581, 10.1007/s007020070080 · DOI
- Widner, 1999, Degradation of tryptophan in neurodegenerative disorders, Adv. Exp. Med. Biol., 467, 133, 10.1007/978-1-4615-4709-9_19 · DOI
- Widner, 2000, Tryptophan degradation and immune activation in Alzheimer's disease, J. Neural Transm., 107, 343, 10.1007/s007020050029 · DOI · Paper page
- Pearson, 1992, Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease, Neurosci. Lett., 144, 199, 10.1016/0304-3940(92)90749-W · DOI
- Guidetti, 2000, Early kynurenergic impairment in Huntington's disease and in a transgenic animal model, Neurosci. Lett., 283, 233, 10.1016/S0304-3940(00)00956-3 · DOI
- Guidetti, 2006, Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice, Neurobiol. Dis., 23, 190, 10.1016/j.nbd.2006.02.011 · DOI · Paper page
- van Ham, 2008, C. elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging, PLoS Genet., 4, e1000027, 10.1371/journal.pgen.1000027 · DOI · Paper page
- Kimura, 1997, daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans, Science, 277, 942, 10.1126/science.277.5328.942 · DOI · Paper page
- Kenyon, 1993, A C. elegans mutant that lives twice as long as wild type, Nature, 366, 461, 10.1038/366461a0 · DOI · Paper page
- Friedman, 1988, A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility, Genetics, 118, 75, 10.1093/genetics/118.1.75 · DOI · Paper page
- Clancy, 2001, Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein, Science, 292, 104, 10.1126/science.1057991 · DOI · Paper page
- Tatar, 2001, A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function, Science, 292, 107, 10.1126/science.1057987 · DOI · Paper page
- Bluher, 2003, Extended longevity in mice lacking the insulin receptor in adipose tissue, Science, 299, 572, 10.1126/science.1078223 · DOI · Paper page
- Jia, 2004, The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span, Development, 131, 3897, 10.1242/dev.01255 · DOI · Paper page
- Honjoh, 2009, Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans, Nature, 457, 726, 10.1038/nature07583 · DOI · Paper page
- Wang, 2009, TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease, J. Cell Biol., 186, 703, 10.1083/jcb.200904090 · DOI
- Kapahi, 2004, Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway, Curr. Biol., 14, 885, 10.1016/j.cub.2004.03.059 · DOI · Paper page
- Luong, 2006, Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity, Cell Metab., 4, 133, 10.1016/j.cmet.2006.05.013 · DOI · Paper page
- Miller, 2011, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice, J. Gerontol. A: Biol. Sci. Med. Sci., 66, 191, 10.1093/gerona/glq178 · DOI · Paper page
- Anisimov, 2011, Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice, Cell Cycle, 10, 4230, 10.4161/cc.10.24.18486 · DOI · Paper page
- Muller, 2008, Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase, Proc. Natl. Acad. Sci. U.S.A., 105, 17073, 10.1073/pnas.0806173105 · DOI · Paper page
Cited by
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Self-citationThe kynurenine pathway and the brain: Challenges, controversies and promises
Schwarcz, R., & Stone, T. W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.003 · Cited by 461
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Tryptophan in health and disease
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 294
Castro-Portuguez, R., & Sutphin, G. L. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110841 · Cited by 281
Metadata
- Authors
- van der Goot, A. T., & Nollen, E. A. A.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 19
- Issue
- 6
- Pages
- 336-344
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1971400022
- Cited by
- 161
- References
- 17
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tryptophan metabolism: entering the field of aging and age-related pathologies. https://app.cochat.ai/papers/10.1016/j.molmed.2013.02.007
- The paper
- van der Goot, A. T., & Nollen, E. A. A. (2013). Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2013.02.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.